Effect of 3D-CTBA Technology Assisted Thoracoscopic Segmentectomy for Early Lung Cancer
Objective To investigate the value of three dimensional pulmonary bronchial revascularization(3D-CTBA)technique in thoracoscopic segmental lung resection for early lung cancer.Methods Sixty early lung cancer patients admitted to Xuchang Central Hospital Affiliated to Henan University of Science and Technology from January 2020 to October 2022 were randomly divided into a control group and a 3D group,with 30 patients in each group,using a random number table method.The control group underwent CT assisted thoracoscopic segmentectomy,while the 3D group underwent 3D-CTBA assisted thoracoscopic segmentectomy.The clinical efficacy and surgery-related indexes of the two groups were compared,as well as the body trauma indexes[C-reactive protein(CRP),epinephrine(E),cortisol(Cor),angiotensin Ⅰ(Ang Ⅰ)],lung function indexes[force expiratory volume in one second(FEV1),forced vital capacity(FVC)and maximal ventilatory volume(MVV)]before and after the surgery,and the complication rates were compared between the two groups.Results The total effective rate of patients in the 3D group was higher than that in the control group(P＜0.05),and the intraoperative blood loss and postoperative total chest drainage volume were lower than those in the control group(P＜0.05),the operation time,chest drainage tube retention time,and hospitalization time were shorter than those in the control group(P＜0.05),CRP,E,Cor,and Ang Ⅰ were all lower than those in the control group(P＜0.05),while FEV1,FVC,and MVV were higher than those in the control group(P＜0.05).There was no statistically difference in the total incidence of complications between the 3D group and the control group(P＞0.05).Conclusion 3D-CTBA assisted thoracoscopic segmental resection is a safe and reliable treatment for early lung cancer,which can reduce body trauma,promote early postoperative recovery,improve lung function and ensure the safety of treatment.
万方数据
维普
